WHO–SARS laboratory collaboration

The WHO–SARS laboratory collaboration was an international research effort that identified the coronavirus responsible for SARS in about a month. Organized by the World Health Organization (WHO) but not directed through a central chain of command, it joined eleven laboratories in parallel investigations, daily exchanges, and shared analysis. Its achievement belonged not to one discoverer but to a network whose members pooled evidence and tested one another’s findings.

Outbreak and research effort

In early February 2003, China’s Ministry of Health informed the WHO that 305 people in Guangdong Province had developed a severe respiratory disease since November, and five had died. The symptoms resembled influenza, but laboratory tests had not detected influenza viruses. A few weeks later, a man returning from China and Hong Kong became ill in Hanoi, while workers at a Hong Kong hospital developed similar symptoms. As further reports arrived, it became clear by early March that SARS was a new disease rather than a new form of flu.

Because the disease spread from person to person, tracking outbreaks and considering quarantine were urgent. Identifying its cause was equally important: that knowledge could enable diagnostic tests and perhaps a vaccine. As it issued a global warning advising travelers about journeys to southern Asia and activated a surveillance system, the WHO also initiated an international search for the pathogen.

On March 15 and 16, the WHO contacted eleven research laboratories in France, Germany, the Netherlands, Japan, the United States, Hong Kong, Singapore, Canada, the United Kingdom, and China. All agreed to participate. On March 17, they began what the WHO called a collaborative multicenter research project, bringing geographically dispersed laboratories into a common investigation without requiring them to work in a single place or institution.

Shared evidence and parallel investigation

The laboratories held daily teleconferences to discuss their work, possible avenues of inquiry, and competing interpretations of current results. They posted electron-microscope photographs of viruses isolated from people with SARS, analyses, and test results on a WHO website. They also exchanged virus samples, enabling laboratories to check each other’s work and learn from it directly.

The arrangement let different laboratories work simultaneously on the same samples, increasing the speed and reach of the investigation. During the first days, the researchers considered and rejected multiple possible causes, including viruses detected in some SARS patients but not others. Those negative findings mattered: eliminating candidates narrowed the field as surely as identifying a promising one.

On March 21, researchers at Hong Kong University isolated a virus that appeared to be a likely candidate. That same day, scientists at the Centers for Disease Control in the United States independently isolated a virus that looked under an electron microscope like a coronavirus. The possibility was initially unexpected because coronaviruses cause serious illness in animals but generally have milder effects in humans. Over the following week, however, laboratories detected the coronavirus in a wide variety of samples from people diagnosed with SARS. Researchers in Germany, the Netherlands, and Hong Kong began sequencing it. In early April, monkeys infected with the coronavirus in a Netherlands laboratory developed SARS. By April 16, only a month after the collaboration began, the laboratories were confident enough to announce that the coronavirus caused the disease.

Collective discovery and self-organization

The work resists assignment to a single discoverer. Electron microscopist Cynthia Goldsmith, working at the Centers for Disease Control and Prevention laboratory in Atlanta, first spotted the coronavirus. But identifying a virus was not the same as demonstrating that it caused SARS. That conclusion depended on weeks of work across the network, including the studies that ruled out other candidates and the analyses that found the coronavirus in many patient samples. The WHO’s account accordingly described the laboratories as having collectively discovered the coronavirus.

The WHO brought the network together, but it did not dictate which laboratories should investigate which viruses or samples, prescribe how they should divide their work, or control how they exchanged information. The laboratories agreed to share relevant data and speak every morning; beyond that, they organized the collaboration themselves. The WHO’s limited authority over academic and government laboratories made top-down command impractical, but in this case that constraint became an advantage. Each laboratory could pursue what seemed most promising and use its own analytical strengths while drawing on the group’s evidence in real time.

This combination of local initiative and shared results made the network more than a collection of parallel efforts. A laboratory’s findings could guide others’ investigations, while samples and analyses circulating among the participants made independent checking possible. The research group organized its own division of labor, yet remained connected closely enough for discoveries and failed leads alike to inform the common search. The result was a multinational alliance that the account presents as working as quickly and efficiently as a top-down organization could have.

Scientific knowledge beyond the network

The collaboration illustrates a broader feature of scientific practice: research is collective not only when investigators co-author a paper or join a formal project, but also because science depends on the open circulation of evidence. Scientists publish results and make data available for inspection rather than reserving discoveries for private use. Others can scrutinize the evidence, challenge conclusions, build new hypotheses, and design further experiments. Even unsuccessful results can help by showing other researchers which paths need not be pursued.

For the SARS finding, the distinction between a virus’s biological properties and the scientific community’s recognition of a causal claim is important. The coronavirus caused SARS before the WHO announced the result; the announcement did not create the underlying relationship. But the claim became an accepted scientific conclusion through scrutiny and agreement among researchers. Laboratories around the world could then work on possible tests and vaccines on the basis of a consensus reached through the research community, rather than through a single authority’s pronouncement.

That consensus does not mean that every scientist independently repeated every experiment. Scientific results should in principle be replicable, but most researchers rely on data and work they have not personally reproduced. Trust in colleagues’ reporting, together with the possibility of scrutiny and replication, enables researchers to build on one another’s work instead of continually retracing it. The WHO–SARS collaboration makes that interdependence concrete: its speed came from sharing evidence across laboratories, while the strength of its conclusion came from their collective effort to test, compare, and interpret it.